Shan 5

BIOLOGICAL2 trials

Sponsors

Shantha Biotechnics Limited

Conditions

DiphtheriaHaemophilus Influenzae Type BHepatitis BPertussisTetanus

Phase 4

Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine

CompletedNCT00674908

Shantha Biotechnics LimitedDiphtheria, Haemophilus Influenzae Type B, Hepatitis B +2

Start: 2008-03-31End: 2009-05-31Updated: 2009-06-25

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

Shantha Biotechnics LimitedDiphtheria, Haemophilus Influenzae Type B, Hepatitis B +2

Start: 2009-01-31End: 2013-02-28Target: 3000Updated: 2009-05-06